GKCAS 2025 Annual Symposium

Kansas City, MO US
April 5, 2025

The Greater Kansas City Allergy Society (GKCAS) hosts an annual symposium to gather the providers, nurses, fellows and interested students and residents of the greater Kansas City area to provide education on the latest relevant topics in allergy and clinical immunology. The symposium provides didactic lectures by renowned experts on relevant topics.

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the Greater Kansas City Allergy Society (GKCAS).  The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 4 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 4 contact hours.

Commercial Support
This activity is supported in part by an independent medical education grant from Grifols.

Target Audience

Practicing allergists
Primary care physicians
Allied healthcare professionals

Learning Objectives

At the conclusion of this Activity learners should be able to…

1. Evaluate the latest advancements in food allergy management.
2. Integrate a conversation of food immunotherapy as an option for patients.
3. Examine asthma and understand updated management guidelines. 
4. Recommend the optimal biologics for asthma. 
5. Review allergic rashes and best practices for management.

Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma & Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months.

Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be ineligible companies. Examples of ineligible companies include:

•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers

The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All relevant financial relationships with ineligible companies have been mitigated.

 

Course summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
  • 4.00 CBRN
Course opens: 
04/05/2025
Course expires: 
12/31/2026
Event starts: 
04/05/2025 - 9:00am CDT
Event ends: 
04/05/2025 - 2:00pm CDT
Rating: 
0

Greater Kansas City Allergy Society Annual Symposium
Cascade Hotel, Country Club Plaza, Kansas City
Saturday, April 5, 2025

All talks will be held in Seville II
Vendor Exhibits will be held in Seville I

7:50 - 8:20 am Product Theater. Breakfast included.
–Not for CME Credit–


8:20 - 8:50     Registration and Vendor Exhibits

8:50 - 9:00     Welcome and Introduction

9:00 - 9:50     Updates on allergic rashes - Marc Serota MD

9:50 - 10:00     Q&A

10:00-10:50     Evolving Landscape of Asthma - Allison Burbank MD

10:50-11:00     Q&A

11:00-11:50     Nuance + Options = Individualized Food Allergy Management - Dave Stukus MD

11:50 - 12:00     Q&A

12:00 - 12:30     Lunch and Vendor Exhibits

12:30 - 1:20     Alpha Gal updates - Scott Commins MD

1:20 - 1:30     Q&A

1:30 – 2:00     Final Announcements and Adjournment

Cascade Hotel
4600 Wornall Road
Kansas City, MO 64112
United States

All relevant financial relationships with ineligible companies have been mitigated.

Brynn Everist, MD, Planner
Advisory Board: Sanofi
Ownership/Executive Role: Amuse

Will Lavery, MD, PhD, Planner
Speaker: Genentech

Allison Burbank, MD, Speaker
Consultant: NIOX Group

Scott Commins, MD, Speaker
Consultant: Genentech, Regeneron
Royalties: UpToDate

Marc Serota, MD, Speaker
Speaker: UCB, Incyte, Sanofi, Regeneron, Dermavent, Pfizer, Aructis, Amgen, Lilly

David Stukus, MD, Speaker
Consultant: Genentech
Researcher: DBV Technologies 

The following have no relevant financial relationships with ineligible companies to disclose:

Mary Jacobson, MD, Planner
Jeehyun Rha, MD, Planner

Available Credit

  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
  • 4.00 CBRN
Please login or create an account to take this course.